Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma. Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M.. Clin Lymphoma Myeloma Leuk. 2015; 680-6: p.680-6. doi:10.1016/j.clml.2015.09.005 10.1016/j.clml.2015.09.005. Epub 2015 Sep 25.Article
Oncostat